About 80 SNPs reached genome-wide significance in association with the risk of PCa in GWAS published (15 (link)-28 (link)) (http://www.genome.gov/gwastudies/). These SNPs were selected for the design of a GoldenGate VeraCode assay (Illumina). After score-based selection, 72 SNPs were retained for genotyping. All DNA samples were extracted from peripheral whole blood by using QIAamp DNA extraction kit (QIAGEN). Genotyping assay was then run on the Illumina BeadXpress Reader. Genotyping data were analyzed and exported using BeadStudio software. The genotyping call rate for the SNPs in this study was 99.86%.